Skip to NavigationSkip to content

Pharmafile - Research and Development News

Genentech, based in California, US, has announced positive results from its phase 3 IMbrave050 trial, after the study met its primary endpoint of...
Moderna’s respiratory syncytial virus (RSV) vaccine has demonstrated positive levels of efficacy in older adults throughout a phase 3 trial. The...
US-based commercial-stage medical technology company Neuronetics Inc., which focuses on designing, developing and marketing products that improve the...
US-based cardiovascular medical device company Shockwave Medical has signed a deal to acquire specialty medical device company Neovasc for around $...
International pharmaceutical company, Luye Pharma, has announced that Rykindo® has received FDA approval for the treatment of schizophrenia in adult...
AstraZeneca has announced that Tezspire (also known as tezepelumab) has received approval from the EMA’s Committee for Medicinal Products for Human...
Inari Medical has announced that the first patient has been enrolled in the DEFIANCE trial. This trial will evaluate the clinical results of Inari’s...
Biopharmaceutical company MediciNova has announced that its phase 2 clinical trial to assess MN-166 (ibudilast) for the treatment of recurring and...
Ajinomoto Co., a Japanese biotech company providing biopharmaceuticals, has signed a license agreement with Exelixis Inc., an oncology-focused...
Clinical stage pharmaceutical company, Oramed Pharmaceuticals, has announced top-line results from its phase 3 randomised, double-blind, placebo-...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches